Futura Medical Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	13.93	3.1	-	-	-	Upgrade
Revenue Growth (YoY)	349.09%	-	-	-	-	Upgrade
Cost of Revenue	4.24	1.33	-	-	-	Upgrade
Gross Profit	9.69	1.77	-	-	-	Upgrade
Selling, General & Admin	6.83	6.69	2.74	2.09	1	Upgrade
Research & Development	1.74	2.05	4.13	3.77	1.93	Upgrade
Other Operating Expenses	-0.13	-	-	-	-	Upgrade
Operating Expenses	8.45	8.74	6.87	5.87	2.93	Upgrade
Operating Income	1.24	-6.96	-6.87	-5.87	-2.93	Upgrade
Interest & Investment Income	0.05	0.07	-	-	0	Upgrade
Pretax Income	1.29	-6.89	-6.87	-5.87	-2.93	Upgrade
Income Tax Expense	-0	-0.38	-1.02	-0.91	-0.52	Upgrade
Net Income	1.29	-6.51	-5.85	-4.96	-2.41	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	-0	Upgrade
Net Income to Common	1.29	-6.51	-5.85	-4.96	-2.41	Upgrade
Shares Outstanding (Basic)	302	295	287	271	244	Upgrade
Shares Outstanding (Diluted)	311	295	287	271	244	Upgrade
Shares Change (YoY)	5.38%	2.59%	6.06%	11.21%	19.09%	Upgrade
EPS (Basic)	0.00	-0.02	-0.02	-0.02	-0.01	Upgrade
EPS (Diluted)	0.00	-0.02	-0.02	-0.02	-0.01	Upgrade
Free Cash Flow	-1.34	-0.94	-6.52	-4.29	-4.55	Upgrade
Free Cash Flow Per Share	-0.00	-0.00	-0.02	-0.02	-0.02	Upgrade
Gross Margin	69.58%	57.22%	-	-	-	Upgrade
Operating Margin	8.93%	-224.57%	-	-	-	Upgrade
Profit Margin	9.29%	-210.03%	-	-	-	Upgrade
Free Cash Flow Margin	-9.59%	-30.17%	-	-	-	Upgrade
EBITDA	1.37	-6.83	-6.85	-5.85	-2.9	Upgrade
EBITDA Margin	9.81%	-220.37%	-	-	-	Upgrade
D&A For EBITDA	0.12	0.13	0.02	0.02	0.03	Upgrade
EBIT	1.24	-6.96	-6.87	-5.87	-2.93	Upgrade
EBIT Margin	8.93%	-224.57%	-	-	-	Upgrade

Updated Sep 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.